Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico;Hospitalisations liées à la diarrhée chez les enfants avant et après la mise en oeuvre de la vaccination monovalente contre le rotavirus au Mexique

Bulletin of the World Health Organization

Volumn 92, Issue 2, 2014, Pages 117-125

  Esparza Aguilar, Marcelino ^a   Gastañaduy, Paul A ^b   Sánchez Uribe, Edgar ^a   Desai, Rishi ^b   Parashar, Umesh D ^c   Richardson, Vesta ^a   Patel, Manish ^c  

^a Ministry of Health   (Mexico)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; DIARRHEA; DRUG EFFECT; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEXICO; PRESCHOOL CHILD; ROTAVIRUS INFECTION; SCHOOL CHILD; SEASON; SOCIOECONOMICS; VACCINATION; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ROTAVIRUS;

CHILD, PRESCHOOL; DIARRHEA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEXICO; ROTAVIRUS VACCINES;

EID: 84893361635     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.125286     Document Type: Article

References (31)

1. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-6. doi: http://dx.doi.org/10.3201/eid1202.050006 PMID:16494759
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD; WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:136-41. doi: http://dx.doi.org/10.1016/S1473-3099(11)70253-5 PMID:22030330
3. Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine 2010;28:754-8. doi: http://dx.doi.org/10.1016/j.vaccine.2009.10.075 PMID:19896451
4. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010;201:1617-24. doi: http://dx.doi.org/10.1086/652403 PMID:20402596
5. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F et al.; Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008;371:1181-9. doi: http://dx.doi.org/10.1016/S0140-6736(08)60524-3 PMID:18395579
6. Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O et al. Reduction of diarrhea-associated hospitalizations among children aged < 5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011;30(Suppl):S16-20. doi: http://dx.doi.org/10.1097/INF.0b013e3181fefc68 PMID:21183835
7. Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011;30:e120-5. doi: http://dx.doi.org/10.1097/INF.0b013e318214b811 PMID:21436757
8. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011;30(Suppl):S6-10. doi: http://dx.doi.org/10.1097/INF.0b013e3181fefa05 PMID:21048524
9. Yen C, Tate JE, Wenk JD, Harris II JM, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011;127:e9-15. doi: http://dx.doi.org/10.1542/peds.2010-1393 PMID:21172995
10. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:606-14. doi: http://dx.doi.org/10.1016/S0140-6736(10)60889-6 PMID:20692030
11. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362:289-98. doi: http://dx.doi.org/10.1056/NEJMoa0904797 PMID:20107214
12. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:615-23. doi: http://dx.doi.org/10.1016/S0140-6736(10)60755-6 PMID:20692031
13. Medina-Gomez OS, Lopez-Arellano O. Asociacion de los tipos de carencia y grado de desarrollo humano con la mortalidad infantil en Mexico, 2008. Cadernos de Saúde Pública 2011;27:1603-10. Spanish.
14. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010;362:299-305. doi: http://dx.doi.org/10.1056/NEJMoa0905211 PMID:20107215
15. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med 2011;365:772-3. doi: http://dx.doi.org/10.1056/NEJMc1100062 PMID:21864191
16. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J 2011;30(Suppl):S11-5. doi: http://dx.doi.org/10.1097/INF.0b013e3181fefb32 PMID:21183834
17. Dirección General de Información en Salud [Internet]. Sistema automatizado de egresos hospitalarios. Mexico City: DGIS; 2012. Available from: http://pda.salud.gob.mx/cubos/ [accessed 6 November 2013]. Spanish.
18. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007;21:192-204.
19. Velázquez FR, Garcia-Lozano H, Rodriguez E, Cervantes Y, Gómez A, Melo M et al. Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease. Pediatr Infect Dis J 2004;23(Suppl):S149-55. doi: http://dx.doi.org/10.1097/01.inf.0000142463.72442.91 PMID:15502694
20. Dirección General de Información en Salud [Internet]. Información dinámica. Mexico City: DGIS; 2012. Available from: http://pda.salud.gob.mx/cubos/ [accessed 6 November 2013]. Spanish.
21. Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009;87:535-41. doi: http://dx.doi.org/10.2471/BLT.08.053819 PMID:19649368
22. Human development report 2009. New York: United Nations Development Programme; 2009. Available from: http://hdr.undp.org/en/media/HDR_2009_EN_Summary.pdf [accessed 6 November 2013].
23. Instituto Nacional de Estadística y Geografía [Internet]. Aguascalientes: Instituto Nacional de Estadística y Geografía; 2013. Available from: http://www.inegi.org.mx/default.aspx [accessed 6 November 2013]. Spanish.
24. Projections of the population of Mexico 2000-2030. Mexico City: National Population Council; 2007.
25. Cortese MM, Parashar UD; Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58(RR-2):1-25. PMID:19194371
26. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22. doi: http://dx.doi.org/10.1056/NEJMoa052434 PMID:16394298
27. Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America-a review. Mem Inst Oswaldo Cruz 2011;106:907-11. PMID:22241109
28. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009;124:465-71. doi: http://dx.doi.org/10.1542/peds.2008-3528 PMID:19581260
29. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200(Suppl 1):S39-48. doi: http://dx.doi.org/10.1086/605035 PMID:19817613
30. Yen C, Figueroa JR, Uribe ES, Carmen-Hernández LD, Tate JE, Parashar UD et al. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis 2011;204:783-6. doi: http://dx.doi.org/10.1093/infdis/jir390 PMID:21810915
31. Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 2010;6:532-42. doi: http://dx.doi.org/10.4161/hv.6.7.11278 PMID:20622508